Page 130 - 00. Complete Version - Progress Report IPEN 2014-2016

130 Radiopharmacy | Progress Report

The Commercial Department (SAC) is respon-
The Production of sible for receiving the product order from the
Radiopharmaceuticals clients weekly or by demand. These radiophar-
is divided in 3 maceuticals are distributed to approximately
different areas 430 Nuclear Medicine Clinics. The main prod-

uct specifications are described as follows:
• Radioisotopes:
( 99m Tc generator,
PET, SPECT A Radioisotopes
ready to use)

• Labeled Genervator:
Compounds: for
diagnosis (PET GERADOR-IPEN-TEC 99m Tc Generator - IP-
and SPECT) and EN-TEC
for therapy The 99m Tc - Generator is a system which pro-
duces Technetium-99m for labeling lyo-
• Lyophilized Kits for philized “kits” and it also is used in nuclear
labeling with 99m Tc medicine for thyroid and salivary glands scin-
tigraphy. Approximately 400 generators are
delivered weekly.

Radioisotopes ready to use

IOD-IPEN-131- I-Na - Sodium iodide solu-
131
tion
For oral study of thyroid gland and therapy
of thyroid cancer and metastases.

CAPS-IPEN I-Na -Sodium iodide capsules
131
For therapy of hyperthyroidism and therapy
of thyroid cancer and metastases.

IOD-IPEN-123 123 I-Na - Sodium iodide solu-
tion
For oral study of thyroid gland.

CROMAT-IPEN Cr – Sodium chromate
51
Used in nuclear medicine for study of red
blood survival and spleen scintigraphy.

GAL-IPEN Ga - Gallium citrate
67
Indicated for localization and detection of
soft tissue tumors and inflammatory process.

Instituto de Pesquisas Energéticas e Nucleares